Furthermore, established biomarkers predictive of response to immunotherapy, such as IFNγ43,44 and CD8+ T cell infiltration45, were not different between responders and non-responders at baseline, suggesting that in colon cancer, different mechanisms of immune evasion may dominate. This evidence concerns the gene CD8A and colonic neoplasm.